Alicia García Arroyo

Title: Alicia García Arroyo: Innovator in Antibody Drug Conjugates

Introduction

Alicia García Arroyo is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibody drug conjugates. With a total of 2 patents, her work is paving the way for innovative cancer treatments.

Latest Patents

Alicia's latest patents focus on antibody drug conjugates, specifically drug conjugates of the formulas [D-(X)-(AA)-(L)-]-Ab and [D-(X)b-(AA)w-(L)-]n-Ab. These conjugates are designed to target cancer cells effectively. The drug moiety D is characterized by a specific formula, which can include various pharmaceutically acceptable forms. The conjugates utilize amino acid units and linker groups to enhance their efficacy in cancer treatment.

Career Highlights

Throughout her career, Alicia has worked with notable companies such as Pharma Mar, S.A. Her experience in the pharmaceutical industry has allowed her to develop groundbreaking technologies that contribute to cancer therapy advancements.

Collaborations

Alicia has collaborated with esteemed colleagues, including Andrés Francesch Solloso and María Garranzo García-Ibarrola. These partnerships have fostered a collaborative environment that enhances innovation in her field.

Conclusion

Alicia García Arroyo is a trailblazer in the development of antibody drug conjugates, with her patents representing significant advancements in cancer treatment. Her contributions to the pharmaceutical industry continue to inspire future innovations.